Major heart study aims to find safer blood thinner for vulnerable patients
NCT ID NCT07383155
Summary
This large study aims to find out which of two common blood thinners is safer for heart attack patients who are also at high risk of bleeding. It will compare bivalirudin against heparin in over 5,000 patients in China during a procedure to open blocked heart arteries. The main goal is to see which drug leads to fewer combined serious problems like death, another heart attack, stroke, or major bleeding within 30 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERCUTANEOUS CORONARY INTERVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.